Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXM5BK
|
||||
Drug Name |
4-{2-[4-(8-Chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)-piperazin-1-yl]-2-oxo-ethyl}-piperidine-1-carboxylic acid methyl ester
|
||||
Synonyms |
CHEMBL354591
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C27H33ClN4O3
|
||||
Canonical SMILES |
COC(=O)N1CCC(CC(=O)N2CCN(CC2)C3c4ccc(Cl)cc4CCc5cccnc35)CC1
|
||||
InChI |
InChI=1S/C27H33ClN4O3/c1-35-27(34)32-11-8-19(9-12-32)17-24(33)30-13-15-31(16-14-30)26-23-7-6-22(28)18-21(23)5-4-20-3-2-10-29-25(20)26/h2-3,6-7,10,18-19,26H,4-5,8-9,11-17H2,1H3
|
||||
InChIKey |
GOGQMUMPNFMTOZ-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.